DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Hydrocortisone butyrateis the generic ingredient in three branded drugs marketed by Actavis Mid Atlantic, Glenmark Generics, Taro Pharm Inds, Bausch, Yamanouchi, Precision Dermat, Lupin Ltd, Teligent, and Taro, and is included in fifteen NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.
There are sixty-seven drug master file entries for hydrocortisone butyrate. One supplier is listed for this compound.
Summary for hydrocortisone butyrate
|Drug Master File Entries:||67|
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||56|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price trends for hydrocortisone butyrate|
|What excipients (inactive ingredients) are in hydrocortisone butyrate?||hydrocortisone butyrate excipients list|
|DailyMed Link:||hydrocortisone butyrate at DailyMed|
Recent Clinical Trials for hydrocortisone butyrate
Identify potential brand extensions & 505(b)(2) entrants
|Wake Forest University||Phase 4|